Your browser doesn't support javascript.
loading
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.
Martini, Alberto; Fossati, Nicola; Karnes, R Jeffrey; Boorjian, Stephen A; Boeri, Luca; Bossi, Alberto; Di Muzio, Nadia; Cozzarini, Cesare; Noris Chiorda, Barbara; Gandaglia, Giorgio; Robesti, Daniele; Bartkowiak, Detlef; Böhmer, Dirk; Shariat, Shahrokh F; Goldner, Gregor; Battaglia, Antonino; Joniau, Steven; Berghen, Charlien; De Meerleer, Gert; Fonteyne, Valérie; Ost, Piet; Van Poppel, Hein; Montorsi, Francesco; Wiegel, Thomas; Briganti, Alberto.
Affiliation
  • Martini A; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Fossati N; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: fossati.nicola@hsr.it.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Boeri L; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
  • Di Muzio N; Department of Radiotherapy, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Cozzarini C; Department of Radiotherapy, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Noris Chiorda B; Department of Radiotherapy, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gandaglia G; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Robesti D; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Bartkowiak D; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Böhmer D; Department of Radiation Oncology, Charité University Hospital, Berlin, Germany.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Goldner G; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
  • Battaglia A; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Berghen C; Department of Radiotherapy, University Hospitals Leuven, Leuven, Belgium.
  • De Meerleer G; Department of Radiotherapy, University Hospitals Leuven, Leuven, Belgium.
  • Fonteyne V; Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
  • Ost P; Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
  • Van Poppel H; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Montorsi F; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Briganti A; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Eur Urol Oncol ; 4(2): 301-304, 2021 04.
Article in En | MEDLINE | ID: mdl-31810893

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur Urol Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur Urol Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: